XFOR is in the HouseSee the comments on the chart; I intentionally left my chart clean as I see this as a great stock for a training session.
If you are interested, leave a note in the comments.
As always, enjoy every sandwich with a great drink ;)
−0.60USD
−101.17 MUSD
122.08 M
About X4 Pharmaceuticals, Inc.
Sector
Industry
CEO
Paula S. Ragan
Website
Headquarters
Boston
Employees (FY)
93
Founded
2010
FIGI
BBG001J1CYH8
X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.
XFOR - 140% UPSIDE- Triangle breakout
- buy pullbacks dips
- Tipranks Analyst rating $22 median price target
- The FDA has designated Rare Pediatric Disease status to X4 Pharmaceuticals (XFOR -2.4%) for its lead asset, mavorixafor, for the treatment of WHIM (Warts, Hypogammaglobulinemia, Infections, and Myelokathex
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of XFOR is 1.36 USD — it has increased by 7.94% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange X4 Pharmaceuticals, Inc. stocks are traded under the ticker XFOR.
X4 Pharmaceuticals, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
XFOR stock is 13.33% volatile and has beta coefficient of 3.44. Check out the list of the most volatile stocks — is X4 Pharmaceuticals, Inc. there?
XFOR earnings for the last quarter are −0.01 USD per share, whereas the estimation was −0.15 USD resulting in a 93.28% surprise. The estimated earnings for the next quarter are −0.15 USD per share. See more details about X4 Pharmaceuticals, Inc. earnings.
X4 Pharmaceuticals, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 128.57 K USD.
Yes, you can track X4 Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
XFOR stock has risen by 2.26% compared to the previous week, the month change is a 4.62% rise, over the last year X4 Pharmaceuticals, Inc. has showed a 0.73% decrease.
XFOR net income for the last quarter is −19.13 M USD, while the quarter before that showed −2.31 M USD of net income which accounts for −729.93% change. Track more X4 Pharmaceuticals, Inc. financial stats to get the full picture.
Today X4 Pharmaceuticals, Inc. has the market capitalization of 228.40 M, it has decreased by 17.01% over the last week.
No, XFOR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, XFOR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade X4 Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 93.00 employees. See our rating of the largest employees — is X4 Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So X4 Pharmaceuticals, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating X4 Pharmaceuticals, Inc. stock shows the neutral signal. See more of X4 Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on X4 Pharmaceuticals, Inc. future price: according to them, XFOR price has a max estimate of 5.00 USD and a min estimate of 1.00 USD. Read a more detailed X4 Pharmaceuticals, Inc. forecast: see what analysts think of X4 Pharmaceuticals, Inc. and suggest that you do with its stocks.